Here, we disclosed that MST4, a member of the GCKIII kinase family, can suppress the EMT, invasive and metastatic potential of HCC cells by inactivating PI3K/AKT/Snail1 axis, and can act as a potential biomarker for the HCC progression and prognosis. This evidence concerns the gene STK26 and hepatocellular carcinoma.